Zentiva Set To Acquire Romania's Solacium
Executive SummaryZentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company, entering into a shared purchase agreement with Siyiara to acquire Romania-based food supplement and OTC medicines producer Solacium.
You may also be interested in...
Romanian self-care industry association, RASCI, provides HBW Insight with an exclusive viewpoint on the country's OTC market in 2018.
Alvogen can sell in the US generic lenalidomide on a volume-limited basis after March 2022, and without volume limitations in early 2026, after settling patent litigation with Celgene relating to the originator’s Revlimid. Dr Reddy's has also settled in Canada.